{"title":"Pulmonary Adenocarcinoma Revealed by Parathyroid Scintigraphy: An Incidental Case to Remember.","authors":"Patricia M Udholm, Søren Møller","doi":"10.2967/jnmt.125.269484","DOIUrl":null,"url":null,"abstract":"<p><p>A 70-y-old woman was referred for a dual-isotope subtraction scintigraphy with <sup>123</sup>I and <sup>99m</sup>Tc-sestamibi in combination with SPECT/CT and ultrasound for the localization of parathyroid adenoma. Aside from a possible parathyroid adenoma, the SPECT/CT scan showed increased and focal <sup>99m</sup>Tc-sestamibi uptake in the right upper lung. A biopsy revealed a primary non-small cell lung adenocarcinoma. Nonparathyroid findings during parathyroid scintigraphy are frequent and can lead to newly diagnosed malignant or premalignant lesions, providing an important opportunity to optimize treatment.</p>","PeriodicalId":16548,"journal":{"name":"Journal of nuclear medicine technology","volume":" ","pages":"271-272"},"PeriodicalIF":1.3000,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of nuclear medicine technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2967/jnmt.125.269484","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
A 70-y-old woman was referred for a dual-isotope subtraction scintigraphy with 123I and 99mTc-sestamibi in combination with SPECT/CT and ultrasound for the localization of parathyroid adenoma. Aside from a possible parathyroid adenoma, the SPECT/CT scan showed increased and focal 99mTc-sestamibi uptake in the right upper lung. A biopsy revealed a primary non-small cell lung adenocarcinoma. Nonparathyroid findings during parathyroid scintigraphy are frequent and can lead to newly diagnosed malignant or premalignant lesions, providing an important opportunity to optimize treatment.